HDAC suppression by VPA contributed to a significant reduction of bladder cancer cell growth and proliferation, not only of the parental but, most importantly, of those sublines with acquired resistance towards temsirolimus. This evidence concerns the gene HDAC9 and urinary bladder carcinoma.